The global percutaneous nephrolithotomy (PCNL) system market size was valued at USD 1.34 billion in 2024 and is predicted to hit around USD 2.7 billion by 2034, rising at a 7.25% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.
Ottawa, Dec. 02, 2025 (GLOBE NEWSWIRE) — The global percutaneous nephrolithotomy (PCNL) system market size is calculated at USD 1.44 billion in 2025 and is expected to reach around USD 2.7 billion by 2034, growing at a CAGR of 7.25% for the forecasted period, driven by the increasing kidney stone cases and growing innovations.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/6394
Key Takeaways
- North America held a major revenue of 38% share of the market in 2024.
- Asia Pacific is expected to witness the fastest growth in the percutaneous nephrolithotomy (PCNL) system market during the forecast period.
- By product/system component, the nephroscopes & endoscopes segment held a major revenue of 25% share of the market in 2024.
- By product/system component, the lithotripsy generators & probes segment is expected to witness the fastest growth in the market between 2025 and 2034.
- By procedure type/approach, the standard (conventional) PCNL segment held a major revenue of 40% share of the market in 2024.
- By procedure type/approach, the mini-PCNL/miniaturized PCNL segment is expected to be the fastest-growing in the market during the forecast period.
- By device type, the reusable rigid/video nephroscopes segment held a major revenue of 55% share of the market in 2024.
- By device type, the single-use/disposable scopes & sheaths segment is expected to witness the fastest growth in the market during the forecast period.
- By end-user/facility type, the hospitals (tertiary & general hospitals) segment held a major revenue of 60% share of the market in 2024.
- By end-user/facility type, the ambulatory surgical centers (ASCs)/day-case units segment is expected to witness the fastest growth in the market during the forecast period.
What are the Percutaneous Nephrolithotomy (PCNL) Systems?
The percutaneous nephrolithotomy (PCNL) system market is driven by increasing kidney stone incidences and advancements in minimally invasive surgical techniques. The percutaneous nephrolithotomy (PCNL) systems refer to the set of medical instruments and devices that utilize a minimally invasive approach to kidney stone removal. The instruments and devices used help to remove complex or large kidney stones, their fragments, as well as in their diagnosis.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
What are the Major Growth Drivers in the Market?
The growing demand for disposable devices is the major driver in the percutaneous nephrolithotomy (PCNL) system market. With the increasing focus on infection control and to minimize the sterilization burden, the demand for these systems are increasing. Additionally, growing technological advancements, a shift towards ambulatory surgical centres, and rising awareness are some of the other market drivers.
What are the Key Drifts in the Market?
The percutaneous nephrolithotomy (PCNL) system market has been expanding due to the growing acquisitions to launch and enhance their use.
- In August 2025, a definitive agreement was announced between Terumo Corporation and OrganOx Limited for the acquisition of all outstanding shares of OrganOx, where approximately USD 1.5 billion was announced as the total transaction value.
What is the Significant Challenge in the Market?
High cost acts as the major limitation in the percutaneous nephrolithotomy (PCNL) system market. The instruments and devices used in these systems are expensive, which limits their adoption rates. Additionally, risk of complications, sterilization challenge, and competition from other treatment alternatives are the other market challenges.
Regional Analysis
Why did North America Dominate the Market in 2024?
In 2024, North America captured the biggest revenue share of 38% in the percutaneous nephrolithotomy (PCNL) system market, due to the presence of advanced healthcare infrastructure. The growing cases of kidney stones due to lifestyle changes and obesity have increased the use of PCNL systems. The growth in healthcare investments also increased their adoption and promoted their innovations. All these factors, along with stringent regulations, contributed to the market growth.
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
What Made the Asia Pacific Grow Rapidly in the Market in 2024?
Asia Pacific is expected to be the fastest-growing region in the percutaneous nephrolithotomy (PCNL) system market during the forecast period, due to growing incidences of kidney stone patients. At the same time, the expanding healthcare sector is increasing the adoption of these systems, where the growing investments are encouraging their advancements. A growing number of urologists, government initiatives, and medical tourism are also increasing their demand and are driving the adoption of minimally invasive techniques, promoting the market growth.
Segmental Insights
By product/system component analysis
Why Did the Nephroscopes & Endoscopes Segment Dominate in the Market in 2024?
By product/system component, the nephroscopes & endoscopes segment led the market with a 25% share in 2024, as it is the core instrument for PCNL. This increased their use as a primary tool for the kidney stones removal, diagnosis, and therapeutic kidney procedures. Moreover, their frequent upgrades increased their adoption rates.
By product/system component, the lithotripsy generators & probes segment is expected to show the highest growth between 2025 and 2034, due to a growing shift towards minimally invasive stone fragmentation. At the same time, the growing production volumes are increasing their demand, which is increasing their innovations and combination with other technologies.
By procedure type/approach analysis
Which Procedure Type/Approach Type Segment Held the Dominating Share of the Market in 2024?
By procedure type/approach, the standard (conventional) PCNL segment held the dominating share of 40% in the market in 2024, as it is broadly accepted as a first-line option for the removal of kidney stones that are more than 2 cm. They also provided higher success rates, which increased their use in complex cases. Their wide availability also increased their accessibility and use, driving their acceptance rates.
By procedure type/approach, the mini-PCNL/miniaturized PCNL segment is expected to show the fastest growth rate during the predicted time, due to its less invasive technique, which reduces the chances of complications and excessive bleeding. Moreover, they promote faster recovery, which is increasing their demand. They are also being used to remove moderate-sized stones, where companies are focusing on their innovations.
Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership
By device type analysis
What Made Reusable Rigid/Video Nephroscopes the Dominant Segment in the Market in 2024?
By device type, the reusable rigid/video nephroscopes segment led the market with 55% share in 2024, due to their high durability and long service life. They provided enhanced accuracy, high-resolution imaging, and efficiency, which increased their use by urologists. Moreover, they were preferred in complex cases.
By device type, the single-use/disposable scopes & sheaths segment is expected to show the highest growth during the predicted time, as they help in reducing the sterilization burden. At the same time, they eliminate the risk of any damage or contamination of the devices, which increases their use. This, in turn, is increasing their sales in emergency conditions.
By end-user/facility type analysis
How the Hospitals (Tertiary & General Hospitals) Segment Dominated the Market in 2024?
By end-user/facility type, the hospitals (tertiary & general hospitals) segment held the largest share of 60% in the market in 2024, due to high PCNL procedural volumes. Moreover, the presence of specialized urology departments increases the use of various tools and devices for complex or emergency kidney stone removal operations. They also provided reimbursement policies, which attracted the patients.
By end-user/facility type, the ambulatory surgical centers (ASCs)/day-case units segment is expected to show the fastest growth rate during the upcoming years, as they offer lower treatment costs and shorter waiting times. Additionally, they also provide minimally invasive PCNL techniques, which are driving their use. Moreover, the growing adoption of advanced devices is also increasing the dependence on them.
Recent Developments in the Market
- In October 2025, a Breakthrough Device Designation (BDD) was granted by the U.S. Food and Drug Administration (FDA) to the Avvio Enhanced Lithotripsy System (ELS) by Avvio Medical, Inc. The potential to reduce complications, expand access to minimally invasive, anesthesia-sparing kidney stone care, and enhance outcomes is highlighted through this designation.
Browse More Insights of Towards Healthcare:
The global orthopedic braces & supports market size is estimated at US$ 4.09 billion in 2025, is projected to grow to US$ 4.35 billion in 2026, and is expected to reach around US$ 7.65 billion by 2035. The market is projected to expand at a CAGR of 6.46% between 2026 and 2035.
The global implantable medical devices market size is calculated at USD 103.14 billion in 2025, grew to USD 109.47 billion in 2026, and is projected to reach around USD 187.16 billion by 2035. The market is expanding at a CAGR of 6.14% between 2026 and 2035.
The global biosensors market size is calculated at USD 32.64 billion in 2025, grew to USD 35.46 billion in 2026, and is projected to reach around USD 74.76 billion by 2035. The market is expanding at a CAGR of 8.64% between 2026 and 2035.
The global medical devices market size is calculated at USD 586.20 billion in 2025, grew to USD 623.37 billion in 2026, and is projected to reach around USD 1083.96 billion by 2035. The market is expanding at a CAGR of 6.34% between 2026 and 2035.
The global outpatient blood pressure monitoring equipment market size is estimated at US$ 1.38 billion in 2025, is projected to grow to US$ 1.50 billion in 2026, and is expected to reach around US$ 3.14 billion by 2035. The market is projected to expand at a CAGR of 8.56% between 2026 and 2035.
The global smart medical devices market size is calculated at US$ 26.62 billion in 2025, grew to US$ 28.55 billion in 2026, and is projected to reach around US$ 53.65 billion by 2035. The market is expanding at a CAGR of 7.26% between 2026 and 2035.
The catheters market size was reported at US$ 40.30 billion in 2025 and is expected to rise to US$ 43.17 billion in 2026. According to forecasts, it will grow at a CAGR of 7.12% to reach US$ 80.17 billion by 2035.
The medical oxygen cylinder market size was reported at US$ 4.64 billion in 2025 and is expected to rise to US$ 4.85 billion in 2026. According to forecasts, it will grow at a CAGR of 4.44% to reach US$ 7.16 billion by 2035.
The coronary stent market size stood at US$ 9.65 billion in 2025, grew to US$ 10.00 billion in 2026, and is forecast to reach US$ 13.74 billion by 2035, expanding at a CAGR of 3.6% from 2026 to 2035.
The global oxygen concentrators market size is estimated at US$ 1.21 billion in 2025, is projected to grow to US$ 1.28 billion in 2026, and is expected to reach around US$ 2.18 billion by 2035. The market is projected to expand at a CAGR of 6.06% between 2025 and 2034.
Percutaneous Nephrolithotomy (PCNL) System Market Key Players List
- Coloplast A/S
- Electro Medical Systems SA
- B. Braun Melsungen AG
- Teleflex Incorporated
- Terumo Corporation
- Dornier MedTech GmbH
- Zimmer Biomet Holdings, Inc.
- Advin Urology
- Merit Medical Systems, Inc.
- Well Lead Medical Co., Ltd.
- Attikouris Enterprises Ltd.
- Allenger Medical Systems Ltd.
- Guangzhou Potent Optotronic Technology Co., Ltd.
- Rocamed SAM
- Surgimedik
Segments Covered in The Report
By Product/System Component
- Nephroscopes & Endoscopes
- Rigid nephroscopes
- Semi-rigid/flexible nephroscopes
- Lithotripsy Generators & Probes
- Holmium laser probes
- Ultrasonic lithotriptors
- Pneumatic/ballistic devices
- Access Sheaths, Dilators & Tract Kits
- Amplatz sheaths, balloon dilators, single-shot dilators
- PCNL Procedure Kits
- Guidewires & Access Needles
- Nephrostomy Catheters & Tubing
- Visualization & Imaging
- Ancillaries/Consumables
- Navigation/Software/Integrated Systems
By Procedure Type/Approach
- Standard (Conventional) PCNL
- Mini-PCNL/Miniaturized PCNL
- Ultra-mini/Micro-PCNL
- Supine PCNL vs Prone PCNL
- Tubeless PCNL/Day-case PCNL protocols
- Staged/Combined procedures
By Device Type
- Reusable Rigid/Video Nephroscopes
- Single-use/Disposable Scopes & Sheaths
- Disposable Access Kits/Dilator Sets
- Reusable Ancillary Instruments
By End-User/Facility Type
- Hospitals (tertiary & general hospitals)
- Urology ORs, high-volume stone centers
- Ambulatory Surgical Centers (ASCs)/Day-case units)
- Specialty Urology Clinics/Stone Centers
- Academic & Research Centers
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
South America
- Brazil
- Argentina
- Rest of South America
Europe
- Western Europe
- Germany
- Italy
- France
- Netherlands
- Spain
- Portugal
- Belgium
- Ireland
- UK
- Iceland
- Switzerland
- Poland
- Rest of Western Europe
- Eastern Europe
- Austria
- Russia & Belarus
- Türkiye
- Albania
- Rest of Eastern Europe
Asia Pacific
- China
- Taiwan
- India
- Japan
- Australia and New Zealand,
- ASEAN Countries (Singapore, Malaysia)
- South Korea
- Rest of APAC
MEA
- GCC Countries
- Saudi Arabia
- United Arab Emirates (UAE)
- Qatar
- Kuwait
- Oman
- Bahrain
- South Africa
- Egypt
- Rest of MEA
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/checkout/6394
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Our Trusted Data Partners
Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.